Monday, October 26, 2026
Home / Health / Merck's melanoma vaccine trial shows reduced recur...
Health

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

CN
CitrixNews Staff
·
Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

Health

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer October 26, 20264:42 AM ET Heard on Morning Edition

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

Audio will be available later today.

Originally reported by NPR. Read the full story at the original source.